Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID
Copyright © 2024 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS..
"Long COVID" is a term used to describe a condition when the symptoms and signs associated with coronavirus disease 2019 (COVID-19) persist for more than three months among patients infected with COVID-19; this condition has been reported globally and poses a serious public health issue. Long COVID can manifest in various forms, highlighting the need for appropriate evaluation and management by experts from various fields. However, due to the lack of clear clinical definitions, knowledge of pathophysiology, diagnostic methods, and treatment protocols, it is necessary to develop the best standard clinical guidelines based on the scientific evidence reported to date. We developed this clinical guideline for diagnosing and treating long COVID by analyzing the latest research data collected from the start of the COVID-19 pandemic until June 2023, along with the consensus of expert opinions. This guideline provides recommendations for diagnosis and treatment that can be applied in clinical practice, based on a total of 32 key questions related to patients with long COVID. The evaluation of patients with long COVID should be comprehensive, including medical history, physical examination, blood tests, imaging studies, and functional tests. To reduce the risk of developing long COVID, vaccination and antiviral treatment during the acute phase are recommended. This guideline will be revised when there is a reasonable need for updates based on the availability of new knowledge on the diagnosis and treatment of long COVID.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Infection & chemotherapy - 56(2024), 1 vom: 23. März, Seite 122-157 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Seo, Jun-Won [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Revised 06.04.2024 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3947/ic.2024.0024 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM37017335X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM37017335X | ||
| 003 | DE-627 | ||
| 005 | 20240406232358.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3947/ic.2024.0024 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1367.xml |
| 035 | |a (DE-627)NLM37017335X | ||
| 035 | |a (NLM)38527781 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Seo, Jun-Won |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2024 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS. | ||
| 520 | |a "Long COVID" is a term used to describe a condition when the symptoms and signs associated with coronavirus disease 2019 (COVID-19) persist for more than three months among patients infected with COVID-19; this condition has been reported globally and poses a serious public health issue. Long COVID can manifest in various forms, highlighting the need for appropriate evaluation and management by experts from various fields. However, due to the lack of clear clinical definitions, knowledge of pathophysiology, diagnostic methods, and treatment protocols, it is necessary to develop the best standard clinical guidelines based on the scientific evidence reported to date. We developed this clinical guideline for diagnosing and treating long COVID by analyzing the latest research data collected from the start of the COVID-19 pandemic until June 2023, along with the consensus of expert opinions. This guideline provides recommendations for diagnosis and treatment that can be applied in clinical practice, based on a total of 32 key questions related to patients with long COVID. The evaluation of patients with long COVID should be comprehensive, including medical history, physical examination, blood tests, imaging studies, and functional tests. To reduce the risk of developing long COVID, vaccination and antiviral treatment during the acute phase are recommended. This guideline will be revised when there is a reasonable need for updates based on the availability of new knowledge on the diagnosis and treatment of long COVID | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Long COVID | |
| 650 | 4 | |a Management | |
| 650 | 4 | |a Persistent symptoms | |
| 650 | 4 | |a Post-COVID condition | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Kim, Seong Eun |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Yoonjung |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Eun Jung |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Tark |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Taehwa |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, So Hee |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Eunjung |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Jacob |e verfasserin |4 aut | |
| 700 | 1 | |a Seo, Yu Bin |e verfasserin |4 aut | |
| 700 | 1 | |a Jeong, Young-Hoon |e verfasserin |4 aut | |
| 700 | 1 | |a Jung, Young Hee |e verfasserin |4 aut | |
| 700 | 1 | |a Choi, Yu Jung |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Joon Young |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infection & chemotherapy |d 2013 |g 56(2024), 1 vom: 23. März, Seite 122-157 |w (DE-627)NLM232968403 |x 2093-2340 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2024 |g number:1 |g day:23 |g month:03 |g pages:122-157 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3947/ic.2024.0024 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2024 |e 1 |b 23 |c 03 |h 122-157 | ||